fingolimod hydrochloride has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, CS; Jin, ZQ; Li, Z; Wang, X | 1 |
1 other study(ies) available for fingolimod hydrochloride and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Topics: Animals; Antigens, CD34; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fingolimod Hydrochloride; Homeodomain Proteins; Lymphocyte Depletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; T-Lymphocytes; Transforming Growth Factor beta1 | 2016 |